ES2913210T3 - Derivados de beta-amino pateamina A y procedimientos para el tratamiento de la leucemia linfocítica crónica - Google Patents

Derivados de beta-amino pateamina A y procedimientos para el tratamiento de la leucemia linfocítica crónica Download PDF

Info

Publication number
ES2913210T3
ES2913210T3 ES17776804T ES17776804T ES2913210T3 ES 2913210 T3 ES2913210 T3 ES 2913210T3 ES 17776804 T ES17776804 T ES 17776804T ES 17776804 T ES17776804 T ES 17776804T ES 2913210 T3 ES2913210 T3 ES 2913210T3
Authority
ES
Spain
Prior art keywords
pharmaceutically acceptable
formula
compound according
antibody
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17776804T
Other languages
English (en)
Spanish (es)
Inventor
Daniel Romo
Kenneth Hull
Mingzhao Zhu
Omar Robles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University System
Original Assignee
Texas A&M University System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University System filed Critical Texas A&M University System
Application granted granted Critical
Publication of ES2913210T3 publication Critical patent/ES2913210T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES17776804T 2016-03-31 2017-03-31 Derivados de beta-amino pateamina A y procedimientos para el tratamiento de la leucemia linfocítica crónica Active ES2913210T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662316299P 2016-03-31 2016-03-31
PCT/US2017/025448 WO2017173313A1 (en) 2016-03-31 2017-03-31 Beta-amimo pateamine a derivatives and methods for treating chronic lymphocytic leukemia

Publications (1)

Publication Number Publication Date
ES2913210T3 true ES2913210T3 (es) 2022-06-01

Family

ID=59965302

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17776804T Active ES2913210T3 (es) 2016-03-31 2017-03-31 Derivados de beta-amino pateamina A y procedimientos para el tratamiento de la leucemia linfocítica crónica

Country Status (7)

Country Link
US (1) US10889596B2 (https=)
EP (1) EP3436007B1 (https=)
JP (1) JP6993348B2 (https=)
CA (1) CA3018192C (https=)
DK (1) DK3436007T3 (https=)
ES (1) ES2913210T3 (https=)
WO (1) WO2017173313A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024254195A1 (en) * 2023-06-06 2024-12-12 Baylor University Methods for treating pancreatic cancer with a combination of des-methyl pateamine a and a class 1 hdac inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0647645A1 (en) 1993-10-12 1995-04-12 Pharma Mar, S.A. Novel antitumoral and antiviral compound
US7737134B2 (en) 2002-03-13 2010-06-15 The Texas A & M University System Anticancer agents and use
US7230021B2 (en) 2002-03-13 2007-06-12 The Texas A&M University System Potent, simplified derivatives of pateamine A
US20130053994A1 (en) * 2011-08-31 2013-02-28 General Electric Company Method and apparatus for monitoring radiopharmaceutical processing
WO2013152299A2 (en) * 2012-04-06 2013-10-10 University Of North Carolina At Chapel Hill Inhibitors of eif4a and derivatives of pateamine a with antiviral activity and use

Also Published As

Publication number Publication date
WO2017173313A1 (en) 2017-10-05
EP3436007A1 (en) 2019-02-06
EP3436007A4 (en) 2019-10-09
EP3436007B1 (en) 2022-03-02
DK3436007T3 (da) 2022-03-14
US10889596B2 (en) 2021-01-12
JP2019510070A (ja) 2019-04-11
CA3018192A1 (en) 2017-10-05
JP6993348B2 (ja) 2022-02-15
US20190177339A1 (en) 2019-06-13
CA3018192C (en) 2025-05-06

Similar Documents

Publication Publication Date Title
AU2017281903B2 (en) Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use
AU2021269433A1 (en) Glucocorticoid receptor agonist and immunoconjugates thereof
JP2024038168A (ja) 生物活性分子コンジュゲート、その調製法及び使用
US20240270736A1 (en) Macrocyclic heterocycles and uses thereof
AU2024205004A1 (en) Anti-EGFR antibody drug conjugates
EP4527415A1 (en) Antibody-drug conjugate containing protein degradation agent bioactive compound, method for preparing same, and use thereof
AU2022389555A1 (en) Antibody-drug conjugate and use thereof
EP4480499A1 (en) Conjugate of antibody-eribulin or derivative thereof, intermediate thereof, preparation method therefor, pharmaceutical composition thereof and use thereof
EP4516321A1 (en) Antibody-drug conjugate, pharmaceutical composition thereof and use thereof
ES2389678T3 (es) Un inhibidor de la quinasa C-Kit para su uso en el tratamiento de tumores del estroma gastrointestinal o mastocitosis
KR20250049293A (ko) 항체-약물 접합체 및 이의 용도
US10870662B2 (en) Alpha-amino pateamine A derivatives and methods for treating chronic lymphocytic leukemia
TW202430173A (zh) 一種抗體藥物偶聯物、製備方法及其應用
ES2913210T3 (es) Derivados de beta-amino pateamina A y procedimientos para el tratamiento de la leucemia linfocítica crónica
US10676504B2 (en) Method for preparing largazole analogs and uses thereof
TW202448519A (zh) 多彈頭抗體偶聯藥物及其製備方法和用途
EP4168003A2 (en) Compounds for targeted degradation of interleukin-2-inducible t-cell kinase and methods of use
HK40091854A (zh) 抗体-药物偶联物及其用途
HK40091854B (zh) 抗体-药物偶联物及其用途